Innovation and Research

Sheba Medical Center is one of the most important innovators of health technology, not only in Israel, but globally.

The future of medical care is being created at Sheba Medical Center.

Through its ARC Innovation Center, Sheba leads the digital healthcare revolution and is the largest launch pad and ecosystem for healthcare innovation and development in Israel.

By challenging the status quo and transforming the standard hospital ecosystem, Sheba is ushering in a new era of seamless integration between innovators, scientists, startups, high level developers, large corporations, investors and academia – all to ultimately better serve its patients and develop breakthrough cures and treatments

Global Game-Changers

Amongst the first in the world: Sheba and National Institutes of Health (NIH) are developing a pan corona vaccine to combat future global outbreaks.

This groundbreaking collaboration between Sheba, the Vaccine Research Center, Walter Reed Army Institute of Research, and Sanofi aims to create a vaccine covering a range of coronaviruses.

Incubating Ideas

Sheba has created one of the world’s leading MedTech innovation platforms.

Sheba offers one of the world’s largest and best medical centers as a place to innovate and test new ideas and technologies. Against the backdrop of Israel’s entrepreneur-driven tech society, they invite inventors and entrepreneurs from around the country to come and get venture funding, mentorship, technical and scientific assistance, and a place to test their ideas and inventions.

As a result, with more than 100 start-ups in its incubator, Sheba originates 20 biomedical patent applications per year.

An example of Sheba’s creative approach is the Nexus program.

Sheba takes graduates of the most elite intelligence tech units in the IDF. The candidates are placed with physicians, therapists and other caregivers to be shadowed almost literally 24 hours a day. The IDF vets observe how the medical professionals work, what they have and what they lack.

And then they are challenged to come up with devices, software and processes that can be solutions. And when great ideas emerge, the program gives them the support, financing and direction to bring the products to market.

Innovating in fields such as big data, telemedicine, virtual reality, artificial intelligence, surgical innovation, and rehabilitation, Sheba’s goal is to rapidly introduce these advances into the market and patients’ hands as quickly as possible.

There are already high-tech medical products for retail sale in the US that were incubated at Sheba with more to come, plus those being used by hospitals and doctor’s offices.

Eytan Stibbe Became Israel’s 2nd Astronaut

Stibbe, a former fighter pilot, blasted off from Cape Canaveral aboard a SpaceX Dragon capsule headed for the International Space Station.

He carried out some 35 experiments for companies and research institutions on his privately-funded “Rakia” (as it’s known in Hebrew) Mission to the ISS.

“The ARC Space Lab is a first of its kind initiative to harness the opportunities of new space endeavors to promote health care innovation and benefit humans in space and on Earth,” said Dr. Harel Baris, who heads the ARC Space Lab.

Read the Full Story


A Pioneer in Virtual Medicine

Sheba has 42,000 telemedicine appointments annually and growing, as the hospital without boundaries expands its care virtually and to countries around the world.

Latest Research

Use of Wearable Devices for Peak Oxygen Consumption Measurement in Clinical Cardiology: Case Report and Literature Review

August 30, 2023

Abstract Background: Oxygen consumption is an important index to evaluate in cardiac patients, particularly those with heart failure, and is measured in the setting of advanced cardiopulmonary exercise testing. However, […]

Read More

Three Elite Intelligence Officers Walked Into Sheba….

August 25, 2023

A few years ago, three graduates of one of Israel’s most elite intelligence units came into Sheba’s ARC Innovation Center to say they wanted to help out in healthcare. Their […]

Read More

In-House Technology Used to Expedite Delivery of CAR-T Therapy

May 10, 2023

They’ve been likened to “giving patients a living drug” against cancer cells—genetically engineered T cells that selectively identify tumor cells and become super-activated upon binding to these cells. Known as […]

Read More

Inspire Technologies Signs Agreement to Conduct Clinical Study of HYLA Blood Sensor

December 27, 2022

The agreement with Sheba Medical Center, 10th ranked hospital in the world, to be the first site for the HYLA Blood Sensor’s Clinical Study Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: […]

Read More

In a first, children with rare genetic diseases get mitochondrial transplants from their mothers

December 27, 2022

At a far distant point in Earth’s ancient past, two separate, single-celled life forms — an archaeon and a bacteria — became one in an act either of symbiosis or […]

Read More

SciSparc Announces Positive Study Results with SCI-210, a Cannabidiol-Based Treatment for Epilepsy

December 14, 2022

The non- clinical study was conducted at The Chaim Sheba Medical Center in Israel SciSparc Ltd. (Nasdaq: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to […]

Read More

Nuvo Group and Sheba Medical Center’s “Sheba BEYOND” Complete First Phase of Collaboration to Create a Virtual Obstetric Solution & Catalyze Research to Advance the Standard of Pregnancy Care

August 25, 2022

Early-stage collaboration includes the evaluation of a new virtual care regimen for managing gestational diabetes and the use of AI to develop personalized care pathways and predictive analytics Nuvo Group—the […]

Read More

Israeli researchers testing if cord blood could help treat autism

August 18, 2022

Umbilical cord blood is normally thrown away at birth. But for World Autism Awareness Day on Friday, a team of doctors and scientists are calling on new mothers to collect […]

Read More

Oral immunotherapy safe, effective for children with high-threshold peanut allergy

June 14, 2022

Fixed-dose OIT appeared safe and effective for younger children with high-threshold peanut allergy, according to a single-center, cross-sectional prospective study published in Annals of Allergy, Asthma & Immunology. Soad Haj […]

Read More

Type 1 diabetes is not always ‘juvenile,’ new Israeli study shows – exclusive

June 14, 2022

Pancreatic cells that produce insulin can be destroyed in overweight teens as well as adults, requiring injections of insulin, according to Sheba study. For many years, diabetologists have been saying […]

Read More

Support Innovation.

Help Sheba Medical Center continue to expand its reach technologically and globally.

Donate Now

Don't miss out.

Sign up our weekly newsletter for the latest updates on medical advances and humanitarian efforts of Israel.